CHARACTERIZATION AND VALIDATION OF NON-HLA ANTIBODIES AS NONINVASIVE BIOMARKERS OF REJECTION IN VASCULARIZED COMPOSITE ALLOTR.
$199,891FY2019Defense Health AgencyDOD
Brigham & Womens Hospital Inc
Investigators
View source on USAspending →CHARACTERIZATION AND VALIDATION OF NON-HLA ANTIBODIES AS NONINVASIVE BIOMARKERS OF REJECTION IN VASCULARIZED COMPOSITE ALLOTR. · GrantIndex